Home » Topics » BioWorld Science

BioWorld Science
RSS

Beijing Scitech-Mq Pharmaceuticals identifies new FGFR4 inhibitors

July 27, 2021

Japan Tobacco divulges new NLRP3 inflammasome inhibitors

July 27, 2021

Yeast study reveals potential cancer therapy approach

July 27, 2021

PolarityTE submits IND for SkinTE in chronic cutaneous ulcers

July 27, 2021

Interim update on first-in-human study of SB-11285 in solid tumors

July 27, 2021

Health Canada approves clinical trials of AT-1501 in kidney transplantation

July 27, 2021

Aurion releases preliminary findings from study of cell therapy for corneal endothelial disease

July 26, 2021

MediWound's MW-005 studied in clinical trials for BCC and nonmelanoma skin cancers

July 26, 2021

FDA clears IND for phase I study of NT-I7 for Kaposi sarcoma

July 26, 2021

Cortexyme selects 3CLpro inhibitor COR-803 to treat coronavirus infections

July 26, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...